Clinical Trials Browser

Malignant mesenchymal tumor, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Breast Neoplasms, Fibrosarcoma, Head and Neck Neoplasms, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Melanoma, Ovarian Neoplasms, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Endometrial Neoplasms, Sarcoma, Endometrial Stromal, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous, Desmoplastic Small Round Cell Tumor

NCT00107276 2013-07-18

S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer

Phase 2 Completed

112 enrolled 6 charts

Breast

Breast Neoplasms

NCT00041067 2013-06-06

S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer

Phase 2 Completed

76 enrolled 6 charts

Breast

Breast Neoplasms

NCT00015938 2013-01-24

S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer

Phase 2 Completed

95 enrolled

Breast

Breast Neoplasms

NCT00025493 2013-01-24

S0029 Docetaxel in Treating Older Women With Metastatic Breast Cancer

Phase 2 Terminated

27 enrolled

Breast

Breast Neoplasms

Clinical Trials

TIBET

SEQUEL-Breast

Appalaches

Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer

Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study

Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast Cancer

PREcoopERA

CFI-400945 and Durvalumab in Patients With Advanced Triple Negative Breast Cancer

CFI-400945 in Patients With Advanced/Metastatic Breast Cancer

NEOLBC

TRAIN-3

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

Proton Radiation for Stage II/III Breast Cancer

TOUCH

Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer

PYTHIA

METEORA-II

Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

Everolimus in Treating Patients WIth Recurrent or Metastatic Breast Cancer

OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer

IND197

A Study of Reolysin For Patients With Advanced/Metastatic Breast Cancer

Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer

Evaluation of Breast Cancer Recurrence Rates Following Surgery in Women With Ductal Carcinoma In Situ

Chemotherapy in Treating Women With Previously Treated Metastatic Breast Cancer

Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer

FB-12

Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery

Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer

PALLET

Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer

Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer

Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer

Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer

Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density

PERIDENO

TREAT-CTC

S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women

TCHL Phase II

S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone

S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer

neurabrax

ABCSG 32

Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer

ACRIN 6657

BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors

S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer

S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer

S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer

S0029 Docetaxel in Treating Older Women With Metastatic Breast Cancer